Imugene tweeted about Dr Bilal Shah delivering an encore presentation at the iwCAR-T 2024 meeting in Florida, on 'Updates for Allo CAR-T PBCAR0191: Bijal Shah'.
What is also interesting is that 2 members of our Scientific Advosry Board also presented at this conference. So Imugene definitely has some firepower in the CAR-T space.
Under CAR-T advances in Lung cancer:
- Tumor immune modulation in solid tumor CAR T-cell therapy: Prasad Adusumilli.
Under Genitourinary cancers.
- Advancing engineered T-cell therapies for solid tumors: Saul Priceman
GLTAH
Why IMU is a multi multi bagger, page-23189
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.6¢ |
Change
0.001(2.22%) |
Mkt cap ! $342.1M | |||
| Open | High | Low | Value | Volume |
| 4.5¢ | 4.7¢ | 4.5¢ | $906.2K | 19.67M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 20 | 9543864 | 4.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.6¢ | 1266571 | 1 |
View Market Depth
| Last trade - 16.10pm 08/11/2024 (20 minute delay) ? |
| IMU (ASX) Chart |